Back to Journals » Lung Cancer: Targets and Therapy » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,975 | Dovepress* | 6,483+ | 930 | 7,413 | |
PubMed Central* | 1,492 | 512 | 2,004 | ||
Totals | 7,975 | 1,442 | 9,417 | ||
*Since 25 March 2021 |
View citations on PubMed Central and Google Scholar